Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-18,992
Closed -$1.7M 1942
2026
Q1
$1.7M Sell
18,992
-41,374
-69% -$3.97M 0.03% 798
2025
Q4
$5.61M Buy
60,366
+32,106
+114% +$3.5M 0.13% 194
2025
Q3
$3.52M Sell
28,260
-6,978
-20% -$887K 0.08% 336
2025
Q2
$4.64M Buy
+35,238
New +$3.99M 0.11% 254
2024
Q4
Sell
-7,912
Closed -$845K 1417
2024
Q3
$845K Buy
7,912
+624
+9% +$63.1K 0.05% 520
2024
Q2
$721K Buy
7,288
+3,051
+72% +$307K 0.04% 650
2024
Q1
$392K Sell
4,237
-537
-11% -$43.3K 0.03% 833
2023
Q4
$360K Sell
4,774
-14,430
-75% -$938K 0.03% 752
2023
Q3
$1.16M Buy
19,204
+13,550
+240% +$930K 0.11% 266
2023
Q2
$408K Buy
+5,654
New +$358K 0.04% 643
2021
Q2
Sell
-3,536
Closed -$308K 752
2021
Q1
$308K Buy
+3,536
New +$350K 0.08% 391

Other funds holding ITRI

Y-Intercept (HK)'s ITRI Position: Q2 2026 in Review

Y-Intercept (HK) sold out of Itron (ITRI) in Q2 2026, closing a stake of 18,992 shares — an estimated $1.7M sold.

Y-Intercept (HK) first reported a position in ITRI in Q1 2021 and held it in 11 quarters. The position peaked at $5.61M in Q4 2025. 413 funds tracked by Wall St. Rank hold ITRI as of Q2 2026.

  • Y-Intercept (HK) reported no remaining Itron position as of Q2 2026 after selling out during the quarter.
  • Y-Intercept (HK) sold 18,992 Itron shares in Q2 2026, an estimated $1.7M.
  • Y-Intercept (HK) first reported a position in Itron in Q1 2021 and held it in 11 quarters.
  • Y-Intercept (HK)'s Itron position peaked at $5.61M in Q4 2025.
  • 413 funds tracked by Wall St. Rank held Itron as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.